The Federal University of São Paulo is a university in the state of São Paulo, Brazil. Until 2005, UNIFESP was exclusively for Health Sciences, but after that year the university became multisubject due to Brazilian Federal Government's University Reform Program.

During the past decade, Federal University of São Paulo conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 6 clinical trials were completed, i.e. on average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Federal University of São Paulo" #1 sponsor was "Federal University of São Paulo" with 104 trials, followed by "Actelion" with 1 trials sponsored, "CellPraxis Bioengenharia Ltda." with 1 trials sponsored, "Duke University" with 1 trials sponsored and "Federal University of Mato Grosso" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Federal University of São Paulo" #1 collaborator was "Fundação de Amparo à Pesquisa do Estado de São Paulo" with 14 trials as a collaborator, "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 3 trials as a collaborator, "Associação Fundo de Incentivo à Pesquisa" with 2 trials as a collaborator, "University of Sao Paulo" with 2 trials as a collaborator and "Alcon Research" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Federal University of São Paulo" are "Pain" (6 trials), "Acute Coronary Syndrome" (3 trials), "Chronic Kidney Disease" (3 trials), "Fibromyalgia" (3 trials) and "Knee Osteoarthritis" (3 trials). Many other conditions were trialed in "Federal University of São Paulo" in a lesser frequency.

Most popular intervention types in "Federal University of São Paulo" are "Drug" (35 trials), "Other" (30 trials), "Procedure" (30 trials), "Device" (10 trials) and "Behavioral" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Acupuncture" (2 trials), "Bupivacaine" (2 trials), "Educational Intervention" (2 trials) and "Kinesiotherapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Federal University of São Paulo" are 85 trials for "All" genders, 25 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Federal University of São Paulo". 2 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Federal University of São Paulo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Federal University of São Paulo, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 55 trials that are defined as “Not Applicable".